Corporate Board Profile
Tech Score: 0/100
Filing Date | Source Excerpt |
---|---|
2011-04-20 | Raafat Fahim, Ph.D., age 57, has been President, Chief Executive Officer and a director of the Company since January 2008 and acting Chief Financial Officer of the Company since May 2008. ... Dr. Fahim's background in the biopharmaceutical industry, position as President and Chief Executive Officer of the Company and right to be nominated to the Board under the terms of his employment agreement with the Company were among the factors considered by the Board of Directors in determining that Dr. Fahim should be nominated for election as a director. |
Data sourced from SEC filings. Last updated: 2025-07-01